Skip to content
Disclosery

EXANE DERIVATIVES: NOBL position timeline

Available 13F reports, 13D and 13G stakes and each Form 3, 4 and 5 line of EXANE DERIVATIVES on NOBL, newest first. How the timeline and the estimate are built.

EXANE DERIVATIVES held 0 NOBL shares at 2020-12-31 per its 13F-HR filed 2021-01-27.

the latest 13F is the newest step

  1. period ended2020-12-31
    13F 0 shares
    Change vs previous 13F -35,412 shares

    13F-HR 0001623883-21-000002 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).

    Exited: the 13F for this period no longer lists the position.

  2. period ended2020-09-30
    13F/A 35,412 shares
    Change vs previous 13F not available

    0.83% of the 13F portfolio, value $2,554,835.

    13F-HR/A 0001623883-20-000010 filed by EXANE DERIVATIVES
    Filed (acceptance time not in the bulk data set), ingested

    Acceptance time not in the bulk data set (spec §4.2).